论文部分内容阅读
目的:观察丹红注射液对不稳定型心绞痛(UA)患者治疗的有效性和安全性。方法:将65例不稳定型心绞痛患者随机分为对照组(30例)和治疗组(35例),对照组给予常规药物治疗,治疗组在对照组基础上加用丹红注射液,用法为丹红注射液30mL加入5%葡萄糖注射液(或0.9%氯化钠注射液)250mL中静脉滴注,观察两组患者治疗前后的心绞痛疗效及心电图上ST-T的变化,并观察药物过敏反应及其他副作用。结果:治疗组较对照组疗效显著,两组总有效率差异有统计学意义(P<0.05)。结论:丹红注射液对不稳定型心绞痛患者的治疗是安全、有效的。
Objective: To observe the effectiveness and safety of Danhong injection in the treatment of patients with unstable angina pectoris (UA). Methods: 65 patients with unstable angina pectoris were randomly divided into control group (30 cases) and treatment group (35 cases). The control group was given conventional drug treatment. The treatment group was given Danhong injection on the basis of the control group. The usage was Danhong injection of 30mL added 5% glucose injection (or 0.9% sodium chloride injection) 250mL intravenous infusion, observed two groups of patients before and after treatment of angina pectoris and electrocardiogram ST-T changes and observed drug allergy And other side effects. Results: The treatment group than the control group significant effect, total effective rate difference between the two groups was statistically significant (P <0.05). Conclusion: Danhong injection in patients with unstable angina is safe and effective.